Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction
Markus Müller, Florian Huber, Marion Arnaud, et al.
Immunity (2023) Vol. 56, Iss. 11, pp. 2650-2663.e6
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Leveraging artificial intelligence in vaccine development: A narrative review
David B. Olawade, Jennifer Teke, Oluwaseun Fapohunda, et al.
Journal of Microbiological Methods (2024) Vol. 224, pp. 106998-106998
Open Access | Times Cited: 21
RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 17
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Leveraging mRNA technology for antigen based immuno-oncology therapies
Charalampos S. Floudas, Siranush Sarkizova, Michele Ceccarelli, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010569-e010569
Open Access | Times Cited: 2
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Florian Huber, Marion Arnaud, Brian J. Stevenson, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 7
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
Aaron M. Miller, Zeynep Koşaloğlu, Luise Westernberg, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 736
Open Access | Times Cited: 5
Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy
Yuriko Minegishi, Yoshimi Haga, Koji Ueda
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1048-1059
Open Access | Times Cited: 4
Tumor-Derived Antigenic Peptides as Potential Cancer Vaccines
Stanislav Sotirov, Ivan Dimitrov
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4934-4934
Open Access | Times Cited: 4
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
Malte Roerden, Andrea Castro, Yufei Cui, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010249-e010249
Open Access | Times Cited: 4
Identification of cancer-associated fibroblast subtypes and prognostic model development in breast cancer: role of the RUNX1/SDC1 axis in promoting invasion and metastasis
Yunhao Wu, Nu Li, Jin Shang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Technological advances in clinical individualized medication for cancer therapy: from genes to whole organism
Jiejing Kai, Xueling Liu, Meijia Wu, et al.
Personalized Medicine (2025), pp. 1-14
Open Access
An in-depth review of AI-powered advancements in cancer drug discovery
Le Huu Nhat Minh, Phat Ky Nguyen, Nguyen Thi Trang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167680-167680
Closed Access
ImmuniT Platform for Improved Neoantigen Prediction in Lung Cancer
Stephanie J. Hachey, Alexander G. Forsythe, Hari B. Keshava, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
β-amino acid substitution in the SIINFEKL antigen alters immunological recognition
Ichwaku Rastogi, John A. Mannone, Ruslan Gibadullin, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Cancer mRNA vaccines: clinical application progress and challenges
Hang Li, Lequan Min, Haotian Du, et al.
Cancer Letters (2025), pp. 217752-217752
Closed Access
Cancer vaccines: from an immunology perspective
Shania Makker, Charlotte Galley, Clare L. Bennett
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 10
Historical perspective and future directions: computational science in immuno-oncology
Cora A. Ricker, Kevin Meli, Eliezer M. Van Allen
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008306-e008306
Open Access | Times Cited: 3
Microbiota-induced inflammatory responses in bladder tumors promote epithelial-mesenchymal transition and enhanced immune infiltration
Qiang Li, Yichao Sun, Kun Zhai, et al.
Physiological Genomics (2024) Vol. 56, Iss. 8, pp. 544-554
Closed Access | Times Cited: 3
Predicting Antigen‐Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist
Marta A. S. Perez, Johanna Chiffelle, Sara Bobisse, et al.
Advanced Science (2024) Vol. 11, Iss. 40
Open Access | Times Cited: 3
Integrating Machine Learning-Enhanced Immunopeptidomics and SARS-CoV-2 Population-Scale Analyses Unveils Novel Antigenic Features for Next-Generation COVID-19 Vaccines
Étienne Caron, Kevin A. Kovalchik, David Hamelin, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
The T Cell Receptor β Chain Repertoire of Tumor Infiltrating Lymphocytes Improves Neoantigen Prediction and Prioritization
Thi Mong Quynh Pham, Thành Nhân Nguyễn, Bui Que Tran Nguyen, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 2
Proteogenomics guided identification of functional neoantigens in non-small cell lung cancer
Ben Nicholas, A.G. Bailey, Katy J. McCann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response
John Nemunaitis, Laura Stanbery, David Willoughby, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5616-5616
Open Access | Times Cited: 4
Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy
Christopher C.T. Sng, Ashwin Adrian Kallor, Benjamin S. Simpson, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top